New York Medical College
Clinical trials sponsored by New York Medical College, explained in plain language.
-
Immune cell therapy trial offers new hope for young hodgkin lymphoma patients
Disease control Not yet recruitingThis early-stage trial tests a new treatment for children, adolescents, and young adults with a certain type of Hodgkin lymphoma that has come back after initial therapy. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and attack cancer…
Phase: PHASE1 • Sponsor: New York Medical College • Aim: Disease control
Last updated Jun 09, 2026 12:09 UTC
-
New combo therapy targets tough hodgkin lymphoma in kids and young adults
Disease control Not yet recruitingThis study tests a new approach for children, teens, and young adults (ages 6 to 29) with poor-risk classical Hodgkin lymphoma that has not responded to standard treatments. Participants will receive strong chemotherapy, a stem cell transplant using their own cells, and then an i…
Phase: PHASE1, PHASE2 • Sponsor: New York Medical College • Aim: Disease control
Last updated Jun 02, 2026 11:58 UTC